000273015 001__ 273015
000273015 005__ 20250127091714.0
000273015 0247_ $$2pmc$$apmc:PMC11588812
000273015 0247_ $$2doi$$a10.1007/s00415-024-12502-1
000273015 0247_ $$2pmid$$apmid:38963440
000273015 0247_ $$2ISSN$$a0367-004X
000273015 0247_ $$2ISSN$$a0012-1037
000273015 0247_ $$2ISSN$$a0340-5354
000273015 0247_ $$2ISSN$$a1432-1459
000273015 0247_ $$2altmetric$$aaltmetric:165564664
000273015 037__ $$aDZNE-2024-01374
000273015 041__ $$aEnglish
000273015 082__ $$a610
000273015 1001_ $$0P:(DE-2719)9000336$$aWalter, Uwe$$b0$$eFirst author
000273015 245__ $$aSystematic review-based guideline 'Parkinson's disease' of the German Society of Neurology: diagnostic use of transcranial sonography.
000273015 260__ $$aHeidelberg$$bSpringer$$c2024
000273015 3367_ $$2DRIVER$$aarticle
000273015 3367_ $$2DataCite$$aOutput Types/Journal article
000273015 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1733133500_30591$$xReview Article
000273015 3367_ $$2BibTeX$$aARTICLE
000273015 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000273015 3367_ $$00$$2EndNote$$aJournal Article
000273015 520__ $$aTranscranial brain parenchyma sonography (TCS) has been recommended as a tool for the early and differential diagnosis of Parkinson's disease (PD) in German and European clinical guidelines. Still, the brain structures to be examined for the diagnostic questions and the requirements for being a qualified investigator were not specified in detail. These issues have now been addressed in the 2023 update of the clinical guideline on PD by the German Society of Neurology (DGN).The recommendations were based on a systematic literature review following PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines.Three diagnostic questions were defined: (1) What is the accuracy of TCS in the differential diagnosis of PD versus atypical and secondary Parkinsonian syndromes? (2) What is the accuracy of TCS in the differential diagnosis of PD versus essential tremor? (3) What is the accuracy of TCS in the diagnosis of PD in persons with typical early symptoms, compared with the diagnosis established by clinical follow-up? The brain structures to be assessed and the level of recommendation were formulated for these questions. The training requirements for being regarded as qualified TCS investigator were stipulated by the responsible medical societies (German Society of Ultrasound in Medicine, DEGUM; German Society for Clinical Neurophysiology and Functional Imaging, DGKN). Finally, the recommendations for these diagnostic questions reached strong consensus (each ≥ 97%) of the guideline committee. Here, the details of review and recommendations are presented.The updated guideline clarifies the diagnostic uses and limitations of TCS in PD.
000273015 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000273015 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000273015 650_7 $$2Other$$aEssential tremor
000273015 650_7 $$2Other$$aNeuroimaging
000273015 650_7 $$2Other$$aParkinsonism
000273015 650_7 $$2Other$$aParkinson’s disease
000273015 650_7 $$2Other$$aSystematic review
000273015 650_7 $$2Other$$aTranscranial ultrasound
000273015 650_2 $$2MeSH$$aHumans
000273015 650_2 $$2MeSH$$aParkinson Disease: diagnostic imaging
000273015 650_2 $$2MeSH$$aParkinson Disease: diagnosis
000273015 650_2 $$2MeSH$$aUltrasonography, Doppler, Transcranial: standards
000273015 650_2 $$2MeSH$$aUltrasonography, Doppler, Transcranial: methods
000273015 650_2 $$2MeSH$$aNeurology: standards
000273015 650_2 $$2MeSH$$aGermany
000273015 650_2 $$2MeSH$$aSocieties, Medical: standards
000273015 650_2 $$2MeSH$$aPractice Guidelines as Topic: standards
000273015 650_2 $$2MeSH$$aDiagnosis, Differential
000273015 7001_ $$aLoewenbrück, Kai F$$b1
000273015 7001_ $$aDodel, Richard$$b2
000273015 7001_ $$0P:(DE-2719)9000306$$aStorch, Alexander$$b3$$udzne
000273015 7001_ $$aTrenkwalder, Claudia$$b4
000273015 7001_ $$0P:(DE-2719)2811373$$aHöglinger, Günter$$b5$$eLast author$$udzne
000273015 7001_ $$aGroup, German Parkinson Guideline$$b6$$eCollaboration Author
000273015 773__ $$0PERI:(DE-600)1421299-7$$a10.1007/s00415-024-12502-1$$gVol. 271, no. 12, p. 7387 - 7401$$n12$$p7387 - 7401$$tJournal of neurology$$v271$$x0367-004X$$y2024
000273015 8564_ $$uhttps://pub.dzne.de/record/273015/files/DZNE-2024-01374%20SUP1.pdf
000273015 8564_ $$uhttps://pub.dzne.de/record/273015/files/DZNE-2024-01374%20SUP2.pdf
000273015 8564_ $$uhttps://pub.dzne.de/record/273015/files/DZNE-2024-01374.pdf$$yOpenAccess
000273015 8564_ $$uhttps://pub.dzne.de/record/273015/files/DZNE-2024-01374%20SUP1.pdf?subformat=pdfa$$xpdfa
000273015 8564_ $$uhttps://pub.dzne.de/record/273015/files/DZNE-2024-01374%20SUP2.pdf?subformat=pdfa$$xpdfa
000273015 8564_ $$uhttps://pub.dzne.de/record/273015/files/DZNE-2024-01374.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000273015 909CO $$ooai:pub.dzne.de:273015$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000273015 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9000336$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b0$$kDZNE
000273015 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9000306$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b3$$kDZNE
000273015 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811373$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b5$$kDZNE
000273015 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000273015 9141_ $$y2024
000273015 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-21
000273015 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-21
000273015 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-10-21
000273015 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2023-10-21
000273015 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-10-21
000273015 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ NEUROL : 2022$$d2023-10-21
000273015 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2023-10-21
000273015 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-21
000273015 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2023-10-21$$wger
000273015 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-21
000273015 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000273015 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-10-21
000273015 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bJ NEUROL : 2022$$d2023-10-21
000273015 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-21
000273015 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000273015 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2023-10-21$$wger
000273015 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-21
000273015 9201_ $$0I:(DE-2719)1111015$$kClinical Research (Munich)$$lClinical Research (Munich)$$x0
000273015 9201_ $$0I:(DE-2719)5000014$$kAG Storch$$lNon-Motor Symptoms in Parkinson's disease$$x1
000273015 980__ $$ajournal
000273015 980__ $$aVDB
000273015 980__ $$aUNRESTRICTED
000273015 980__ $$aI:(DE-2719)1111015
000273015 980__ $$aI:(DE-2719)5000014
000273015 9801_ $$aFullTexts